LLY

749.3

-0.7%↓

JNJ

177.72

-0.2%↓

ABBV

216.91

-0.64%↓

UNH

348.68

-1.2%↓

AZN

78.03

-1.9%↓

LLY

749.3

-0.7%↓

JNJ

177.72

-0.2%↓

ABBV

216.91

-0.64%↓

UNH

348.68

-1.2%↓

AZN

78.03

-1.9%↓

LLY

749.3

-0.7%↓

JNJ

177.72

-0.2%↓

ABBV

216.91

-0.64%↓

UNH

348.68

-1.2%↓

AZN

78.03

-1.9%↓

LLY

749.3

-0.7%↓

JNJ

177.72

-0.2%↓

ABBV

216.91

-0.64%↓

UNH

348.68

-1.2%↓

AZN

78.03

-1.9%↓

LLY

749.3

-0.7%↓

JNJ

177.72

-0.2%↓

ABBV

216.91

-0.64%↓

UNH

348.68

-1.2%↓

AZN

78.03

-1.9%↓

Search

Repligen Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

113.72 0.22

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

112.88

Max

115.54

Pagrindiniai rodikliai

By Trading Economics

Pajamos

9M

15M

Pardavimai

13M

182M

P/E

Sektoriaus vid.

466.89

35.664

Pelno marža

8.152

Darbuotojai

1,778

EBITDA

7.7M

44M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+51.56% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

68M

6.8B

Ankstesnė atidarymo kaina

113.5

Ankstesnė uždarymo kaina

113.72

Naujienos nuotaikos

By Acuity

42%

58%

132 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Repligen Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-12 22:41; UTC

Pagrindinės rinkos jėgos

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

2025-09-12 16:04; UTC

Pagrindinės rinkos jėgos

Upexi Shares Climb on Solana Gains

2025-09-14 23:48; UTC

Rinkos pokalbiai

Oil Futures Mixed Amid Divergent Signals -- Market Talk

2025-09-14 23:41; UTC

Rinkos pokalbiai

Gold Edges Lower on Likely Technical Correction -- Market Talk

2025-09-14 23:38; UTC

Rinkos pokalbiai

China's Economic Activity Data May Continue Reflecting Slowdown -- Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Infratil May Need to Be More Aggressive With Asset Sales -- Market Talk

2025-09-14 23:13; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-09-14 23:04; UTC

Rinkos pokalbiai

Aristocrat's Interactive Unit Appears in Safe Hands -- Market Talk

2025-09-13 08:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-09-12 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-09-12 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-12 20:09; UTC

Uždarbis

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

2025-09-12 19:23; UTC

Rinkos pokalbiai

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

2025-09-12 19:16; UTC

Rinkos pokalbiai

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

2025-09-12 19:03; UTC

Rinkos pokalbiai

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

2025-09-12 18:59; UTC

Rinkos pokalbiai

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

2025-09-12 18:38; UTC

Rinkos pokalbiai
Uždarbis

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

2025-09-12 18:33; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

2025-09-12 18:22; UTC

Rinkos pokalbiai

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

2025-09-12 16:56; UTC

Rinkos pokalbiai

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

2025-09-12 16:22; UTC

Uždarbis

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

2025-09-12 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-12 16:19; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

2025-09-12 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-09-12 16:11; UTC

Uždarbis

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

2025-09-12 15:37; UTC

Rinkos pokalbiai

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

2025-09-12 15:22; UTC

Rinkos pokalbiai

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

2025-09-12 15:07; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Repligen Corp Prognozė

Kainos tikslas

By TipRanks

51.56% į viršų

12 mėnesių prognozė

Vidutinis 172.08 USD  51.56%

Aukščiausias 220 USD

Žemiausias 125 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Repligen Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

15 ratings

11

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

125.31 / 140.7Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

132 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat